Cellular and molecular mechanisms of gastrointestinal ulcer healing.

Andrzej S Tarnawski
Author Information
  1. Andrzej S Tarnawski: Department of Medicine, VA Long Beach Healthcare System Long Beach, Long Beach, California 90822, USA. atarnawski@yahoo.com

Abstract

This paper reviews cellular and molecular mechanisms of gastrointestinal ulcer healing. Ulcer healing, a genetically programmed repair process, includes inflammation, cell proliferation, re-epithelialization, formation of granulation tissue, angiogenesis, interactions between various cells and the matrix and tissue remodeling, all resulting in scar formation. All these events are controlled by the cytokines and growth factors (EGF, PDGF, KGF, HGF, TGFbeta, VEGF, angiopoietins) and transcription factors activated by tissue injury in spatially and temporally coordinated manner. These growth factors trigger mitogenic, motogenic and survival pathways utilizing Ras, MAPK, PI-3K/Akt, PLC-gamma and Rho/Rac/actin signaling. Hypoxia activates pro-angiogenic genes (e.g., VEGF, angiopoietins) via HIF, while serum response factor (SRF) is critical for VEGF-induced angiogenesis, re-epithelialization and muscle restoration. EGF, its receptor, HGF and Cox2 are important for epithelial cell proliferation, migration re-epithelializaton and reconstruction of gastric glands. VEGF, angiopoietins, nitric oxide, endothelin and metalloproteinases are important for angiogenesis, vascular remodeling and mucosal regeneration within ulcer scar. Circulating progenitor cells are also important for ulcer healing. Local gene therapy with VEGF + Ang1 and/or SRF cDNAs dramatically accelerates esophageal and gastric ulcer healing and improves quality of mucosal restoration within ulcer scar. Future directions to accelerate and improve healing include the use of stem cells and tissue engineering.

References

  1. J Biol Chem. 1999 Oct 15;274(42):30196-201 [PMID: 10514510]
  2. J Physiol Paris. 2001 Jan-Dec;95(1-6):325-35 [PMID: 11595457]
  3. Ann N Y Acad Sci. 1995 Sep 7;766:416-30 [PMID: 7486687]
  4. J Mol Med (Berl). 2003 Oct;81(10):627-36 [PMID: 13679997]
  5. Am J Physiol. 1999 Jun;276(6 Pt 1):G1345-55 [PMID: 10362637]
  6. J Clin Gastroenterol. 1990;12 Suppl 1:S139-47 [PMID: 2212540]
  7. J Pharmacol Exp Ther. 2004 Dec;311(3):982-8 [PMID: 15302893]
  8. J Clin Gastroenterol. 1998;27 Suppl 1:S12-20 [PMID: 9872493]
  9. Am J Pathol. 1999 Nov;155(5):1759-66 [PMID: 10550332]
  10. J Biol Chem. 1998 Nov 13;273(46):30336-43 [PMID: 9804796]
  11. Endocr Rev. 2004 Aug;25(4):581-611 [PMID: 15294883]
  12. Nat Med. 2002 Sep;8(9):1011-7 [PMID: 12195435]
  13. Nature. 1997 Apr 17;386(6626):671-4 [PMID: 9109485]
  14. Gastroenterology. 2004 Jun;126(7):1809-18 [PMID: 15188176]
  15. Gastroenterology. 2002 Feb;122(2):458-68 [PMID: 11832460]
  16. Microsc Res Tech. 2001 Jun 15;53(6):396-408 [PMID: 11525257]
  17. Nat Med. 1999 Dec;5(12):1418-23 [PMID: 10581086]
  18. Am J Pathol. 2002 Oct;161(4):1449-57 [PMID: 12368217]
  19. Cell. 1996 Dec 27;87(7):1161-9 [PMID: 8980223]
  20. J Clin Gastroenterol. 1991;13 Suppl 1:S42-7 [PMID: 1719066]
  21. Digestion. 2004;70(2):127-38 [PMID: 15375341]
  22. J Clin Invest. 1999 May;103(9):R31-8 [PMID: 10225980]
  23. Gastroenterology. 1994 Apr;106(4):1106-11 [PMID: 8143978]
  24. Gastroenterology. 1992 Feb;102(2):695-8 [PMID: 1732139]
  25. J Clin Gastroenterol. 1990;12 Suppl 1:S148-57 [PMID: 2212541]
  26. Life Sci. 2001 Nov 9;69(25-26):3005-18 [PMID: 11758827]
  27. Ann Surg. 1991 Oct;214(4):414-25; discussion 426-7 [PMID: 1719945]
  28. Science. 1997 Jul 4;277(5322):55-60 [PMID: 9204896]
  29. J Biol Chem. 1999 May 28;274(22):15732-9 [PMID: 10336473]
  30. J Gastroenterol. 2003;38(5):431-5 [PMID: 12768384]
  31. Cell. 1996 Dec 27;87(7):1153-5 [PMID: 8980221]
  32. Bull Mem Acad R Med Belg. 2001;156(3-4):175-84; discussion 185 [PMID: 11789398]
  33. Gastroenterology. 1998 Apr;114(4):706-13 [PMID: 9516391]
  34. Am J Pathol. 1998 Jun;152(6):1617-24 [PMID: 9626065]
  35. Dig Dis Sci. 1998 Sep;43(9 Suppl):90S-98S [PMID: 9753233]
  36. Gut. 2000 Feb;46(2):286-92 [PMID: 10644327]
  37. FASEB J. 2004 Aug;18(11):1264-6 [PMID: 15180964]
  38. Drug News Perspect. 2000 Apr;13(3):158-68 [PMID: 12937606]
  39. Cell. 1996 Dec 27;87(7):1171-80 [PMID: 8980224]
  40. J Physiol Pharmacol. 1998 Dec;49(4):479-88 [PMID: 10069690]
  41. Nature. 1990 Jan 4;343(6253):82-5 [PMID: 2296294]
  42. Gastroenterology. 2001 Nov;121(5):1040-7 [PMID: 11677194]
  43. Gastroenterology. 1998 Mar;114(3):493-502 [PMID: 9496939]

MeSH Term

Cell Proliferation
Cell Survival
Cicatrix
Cytokines
Cytoskeleton
Gastric Mucosa
Growth Substances
Humans
Neovascularization, Physiologic
Signal Transduction
Stomach Ulcer
Wound Healing

Chemicals

Cytokines
Growth Substances

Word Cloud

Created with Highcharts 10.0.0ulcerhealingtissueVEGFangiogenesiscellsscarfactorsangiopoietinsimportantmolecularmechanismsgastrointestinalcellproliferationre-epithelializationformationremodelinggrowthEGFHGFSRFrestorationgastricmucosalwithinpaperreviewscellularUlcergeneticallyprogrammedrepairprocessincludesinflammationgranulationinteractionsvariousmatrixresultingeventscontrolledcytokinesPDGFKGFTGFbetatranscriptionactivatedinjuryspatiallytemporallycoordinatedmannertriggermitogenicmotogenicsurvivalpathwaysutilizingRasMAPKPI-3K/AktPLC-gammaRho/Rac/actinsignalingHypoxiaactivatespro-angiogenicgenesegviaHIFserumresponsefactorcriticalVEGF-inducedmusclereceptorCox2epithelialmigrationre-epithelializatonreconstructionglandsnitricoxideendothelinmetalloproteinasesvascularregenerationCirculatingprogenitoralsoLocalgenetherapy+Ang1and/orcDNAsdramaticallyacceleratesesophagealimprovesqualityFuturedirectionsaccelerateimproveincludeusestemengineeringCellular

Similar Articles

Cited By (127)